Home/Filings/4/0000950170-24-010870
4//SEC Filing

BRYANT DOUGLAS C 4

Accession 0000950170-24-010870

CIK 0001906324other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:06 PM ET

Size

13.7 KB

Accession

0000950170-24-010870

Insider Transaction Report

Form 4
Period: 2024-01-31
BRYANT DOUGLAS C
DirectorChairman & CEO
Transactions
  • Award

    Common Stock

    2024-01-31+6,761542,331 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-3112,09312,094 total
    Common Stock (12,093 underlying)
  • Tax Payment

    Common Stock

    2024-01-31$68.51/sh2,476$169,631539,855 total
  • Tax Payment

    Common Stock

    2024-01-31$68.51/sh4,954$339,399546,994 total
  • Award

    Common Stock

    2024-01-31+12,093551,948 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-316,76113,522 total
    Common Stock (6,761 underlying)
Footnotes (5)
  • [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
  • [F2]Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
  • [F3]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F4]6,761 shares vested on January 31, 2024; the remaining 13,522 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
  • [F5]12,093 shares vested on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

Documents

1 file

Issuer

QuidelOrtho Corp

CIK 0001906324

Entity typeother

Related Parties

1
  • filerCIK 0001406652

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:06 PM ET
Size
13.7 KB